| Overview |
| bs-1451R-PE |
| PAFAH POLYCLONAL ANTIBODY, PE Conjugated |
| WB |
| Human, Mouse, Rat, Pig, Rabbit |
| Dog |
| Specifications |
| PE |
| Rabbit |
| KLH conjugated synthetic peptide derived from human PAFAH2 |
| 301-441/441 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 7941 |
| Q13093 |
| Secreted, Extracellular matrix |
| PAFAD; PAFAH; LP-PLA2; LDL-PLA2; Platelet-activating factor acetylhydrolase; PAF acetylhydrolase; 1-alkyl-2-acetylglycerophosphocholine esterase; 2-acetyl-1-alkylglycerophosphocholine esterase; Group-VIIA phospholipase A2; gVIIA-PLA2; LDL-associated phospholipase A2; LDL-PLA(2); PAF 2-acylhydrolase; PLA2G7 |
| Modulates the action of platelet-activating factor (PAF) by hydrolyzing the sn-2 ester bond to yield the biologically inactive lyso-PAF. Has a specificity for substrates with a short residue at the sn-2 position. It is inactive against long-chain phospholipids. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz